Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

ClinicalTrials.gov ID: NCT06024746

Public ClinicalTrials.gov record NCT06024746. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 16, 2026, 10:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Combined Efficacy and Safety of an Early, Intensive, Management Strategy With Finerenone and SGLT2 Inhibitor in Patients Hospitalized With Heart Failure (CONFIRMATION-HF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety of treatment in patients hospitalized with heart failure.

Study identification

NCT ID
NCT06024746
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Colorado Prevention Center
Other
Enrollment
1,500 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 9, 2024 (Actual)
Primary completion
Nov 2027 (Estimated)
Completion
Nov 2027 (Estimated)
Last update posted
Sep 10, 2026

2024 – 2027

United States locations

U.S. sites
46
U.S. states
20
U.S. cities
43
Facility City State ZIP Site status
CON-10004 Fairhope, AL Investigational Site Fairhope Alabama 36532 Recruiting
Phoenix, AZ Investigative Site CON-10115 Phoenix Arizona 85006 Recruiting
Chula Vista, CA Investigative Site CON-10111 Chula Vista California 91911 Recruiting
CON-10075 El Centro, CA Investigational Site El Centro California 92243 Recruiting
CON-10024 Sacramento, CA Investigational Site Sacramento California 95816 Recruiting
San Francisco, CA Investigative Site CON-10315 San Francisco California 94110 Recruiting
CON-10023, San Francisco, CA San Francisco California 94118 Recruiting
CON-10109, Van Nuys, CA Van Nuys California 91405 Recruiting
CON-10001, Aurora, CO Aurora Colorado 80045 Recruiting
CON-10005, Denver, CO Denver Colorado 80204 Recruiting
Bradenton, FL Investigative Site CON-10125 Bradenton Florida 34209 Recruiting
Fort Lauderdale, FL Investigative Site CON-10114 Fort Lauderdale Florida 33308 Recruiting
CON-10078, Hialeah, FL Hialeah Florida 33012 Recruiting
CON-10105, Miami, FL Miami Florida 33135 Recruiting
CON-10113, Miramar, FL Miramar Florida 33027 Recruiting
CON-10022 Atlanta, GA Investigational Site Atlanta Georgia 30303 Recruiting
CON-10021, Glenview, IL Glenview Illinois 60026 Recruiting
CON-10041, Island Lake, IL Island Lake Illinois 60042 Recruiting
CON-10025, Naperville, IL Naperville Illinois 60540 Recruiting
CON-10019, Peoria, IL Peoria Illinois 61603 Recruiting
CON-10064, Merrillville, IN Merrillville Indiana 46410 Recruiting
CON-10080, Lexington, KY Lexington Kentucky 40503 Recruiting
Lexington, KY Investigative Site CON-10118 Lexington Kentucky 40536 Recruiting
CON-10086, Louisville, Kentucky Louisville Kentucky 40205 Recruiting
CON-10079, Paducah, KY Paducah Kentucky 42003 Recruiting
CON-10030 Baton Rouge, LA Investigational Site Baton Rouge Louisiana 70808 Recruiting
CON-10090, West Monroe, LA West Monroe Louisiana 71291 Recruiting
Minneapolis, MN Investigative Site CON-10035 Minneapolis Minnesota 55417 Recruiting
CON-10002 Kansas City, MO Investigative Site Kansas City Missouri 64111 Recruiting
CON-10018, Omaha, NE Omaha Nebraska 68105 Recruiting
CON-10318, Charlotte, NC Charlotte North Carolina 28207 Recruiting
Greenville, NC Investigative Site CON-10122 Greenville North Carolina 27834 Recruiting
Morrisville, NC Investigative Site CON-10317 Morrisville North Carolina 27560 Recruiting
CON-10119, Centerville, OH Centerville Ohio 45459 Recruiting
Philadelphia, PA Investigative Site CON-10068 Philadelphia Pennsylvania 19107 Recruiting
CON-10051, Chattanooga, TN Chattanooga Tennessee 37403 Recruiting
CON-10045 Amarillo, TX Investigational Site Amarillo Texas 79106 Recruiting
CON-10015 Austin, TX Investigational Site Austin Texas 78705 Recruiting
CON-10304, Denison, TX Denison Texas 75020 Recruiting
CON-10301, Fort Worth, TX Fort Worth Texas 76104 Recruiting
CON-10085, Houston, TX Houston Texas 77030 Recruiting
Houston, TX Investigative Site CON-10320 Houston Texas 77058 Recruiting
Texarkana, TX Investigative Site CON-10319 Texarkana Texas 75503 Recruiting
CON-10305, Layton, UT Layton Utah 84041 Recruiting
CON-10009, Norfolk, VA Norfolk Virginia 23507 Recruiting
Salem, VA Investigative Site CON-10048 Salem Virginia 24153 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06024746, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2026 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06024746 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →